Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. (Q36871712)
Jump to navigation
Jump to search
scientific article published on July 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. |
scientific article published on July 2007 |
Statements
1 reference
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. (English)
1 reference
David M Kurtz
1 reference
Loren K Tschetter
1 reference
Jacob B Allred
1 reference
Susan M Geyer
1 reference
Paul J Kurtin
1 reference
Wesley D Putnam
1 reference
Kendrith M Rowland
1 reference
Martin Wiesenfeld
1 reference
Gamini S Soori
1 reference
Richard C Tenglin
1 reference
Albert M Bernath
1 reference
Thomas E Witzig
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference